Annual Drug Patent Expiration for LUPKYNIS
Lupkynis is a drug marketed by Aurinia and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
This drug has one hundred and sixty-six patent family members in thirty-five countries.
The generic ingredient in LUPKYNIS is voclosporin. One registered supplier for this compound. Additional details are available on the voclosporin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Aurinia LUPKYNIS